Chen Guanzi, Xu Wenli, Long Zhicong, Chong Yutian, Lin Bingliang, Jie Yusheng
Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
J Clin Transl Hepatol. 2024 Jan 28;12(1):79-90. doi: 10.14218/JCTH.2023.00224. Epub 2023 Sep 1.
The liver is the largest glandular organ in the body and has a unique distribution of cells and biomolecules. However, the treatment outcome of end-stage liver disease is extremely poor. Single-cell sequencing is a new advanced and powerful technique for identifying rare cell populations and biomolecules by analyzing the characteristics of gene expression between individual cells. These cells and biomolecules might be used as potential targets for immunotherapy of liver diseases and contribute to the development of precise individualized treatment. Compared to whole-tissue RNA sequencing, single-cell RNA sequencing (scRNA-seq) or other single-cell histological techniques have solved the problem of cell population heterogeneity and characterize molecular changes associated with liver diseases with higher accuracy and resolution. In this review, we comprehensively summarized single-cell approaches including transcriptomic, spatial transcriptomic, immunomic, proteomic, epigenomic, and multiomic technologies, and described their application in liver physiology and pathology. We also discussed advanced techniques and recent studies in the field of single-cell; our review might provide new insights into the pathophysiological mechanisms of the liver to achieve precise and individualized treatment of liver diseases.
肝脏是人体最大的腺器官,具有独特的细胞和生物分子分布。然而,终末期肝病的治疗效果极差。单细胞测序是一种先进且强大的新技术,通过分析单个细胞之间的基因表达特征来识别稀有细胞群体和生物分子。这些细胞和生物分子可能作为肝病免疫治疗的潜在靶点,并有助于精准个体化治疗的发展。与全组织RNA测序相比,单细胞RNA测序(scRNA-seq)或其他单细胞组织学技术解决了细胞群体异质性问题,并能以更高的准确性和分辨率表征与肝病相关的分子变化。在本综述中,我们全面总结了包括转录组学、空间转录组学、免疫组学、蛋白质组学、表观基因组学和多组学技术在内的单细胞方法,并描述了它们在肝脏生理学和病理学中的应用。我们还讨论了单细胞领域的先进技术和最新研究;我们的综述可能为肝脏的病理生理机制提供新的见解,以实现肝病的精准个体化治疗。